This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Viral Infections  • Immunization  • Asthma  • Alert me on articles by topic

Influenza and Pneumococcal Vaccination Coverage Among Persons Aged 65 Years and Persons Aged 18-64 Years With Diabetes or Asthma—United States, 2003

JAMA. 2004;292:2715-2716.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MMWR. 2004;53:1007-1012

2 tables omitted

Vaccination of persons at risk for complications from influenza and pneumococcal disease is a key public health strategy for preventing associated morbidity and mortality in the United States. Risk factors include older age and medical conditions that increase the risk for complications from infections. During the 1990-1999 influenza seasons, more than 32,000 deaths each year among persons aged 65 years were attributed to complications from influenza infection.¹ National health objectives for 2010 call for 90% influenza and pneumococcal vaccination coverage among noninstitutionalized persons aged 65 years and 60% coverage among noninstitutionalized persons aged 18-64 years who have risk factors (e.g., diabetes or asthma) for complications from infections² (objective nos. 14.29a–d). To estimate influenza and pneumococcal vaccination coverage among these populations, CDC analyzed data from the 2003 Behavioral Risk Factor Surveillance System (BRFSS) survey.* This report summarizes the results of that analysis, which indicated that (1) . . . [Full Text of this Article]

Reported by: